Concepts (197)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ovarian Neoplasms | 8 | 2022 | 464 | 2.550 |
Why?
|
| Brenner Tumor | 3 | 2021 | 3 | 1.650 |
Why?
|
| Neoplasms, Complex and Mixed | 2 | 2020 | 5 | 1.200 |
Why?
|
| Ovary | 2 | 2021 | 384 | 1.140 |
Why?
|
| Fallopian Tube Neoplasms | 3 | 2022 | 14 | 1.010 |
Why?
|
| Uterine Neoplasms | 3 | 2022 | 112 | 0.980 |
Why?
|
| Carcinoma in Situ | 2 | 2022 | 72 | 0.930 |
Why?
|
| Immunohistochemistry | 8 | 2021 | 1760 | 0.900 |
Why?
|
| Biomarkers, Tumor | 10 | 2021 | 1718 | 0.860 |
Why?
|
| Endometrial Neoplasms | 4 | 2023 | 114 | 0.850 |
Why?
|
| Trophoblastic Neoplasms | 1 | 2022 | 5 | 0.800 |
Why?
|
| Neoplasms, Cystic, Mucinous, and Serous | 1 | 2022 | 9 | 0.790 |
Why?
|
| Gestational Trophoblastic Disease | 1 | 2022 | 10 | 0.790 |
Why?
|
| Pregnancy, Ectopic | 1 | 2022 | 23 | 0.780 |
Why?
|
| Appendiceal Neoplasms | 1 | 2022 | 20 | 0.770 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2022 | 46 | 0.760 |
Why?
|
| HIV Seropositivity | 1 | 2023 | 131 | 0.760 |
Why?
|
| Herpesviridae Infections | 1 | 2023 | 147 | 0.750 |
Why?
|
| Sex Cord-Gonadal Stromal Tumors | 1 | 2020 | 12 | 0.690 |
Why?
|
| Granulosa Cell Tumor | 1 | 2020 | 39 | 0.680 |
Why?
|
| Cystadenocarcinoma, Serous | 3 | 2017 | 58 | 0.650 |
Why?
|
| Adenocarcinoma, Mucinous | 2 | 2021 | 39 | 0.640 |
Why?
|
| Cell Lineage | 1 | 2021 | 369 | 0.620 |
Why?
|
| Endometrial Stromal Tumors | 1 | 2018 | 1 | 0.580 |
Why?
|
| Endodermal Sinus Tumor | 1 | 2016 | 6 | 0.510 |
Why?
|
| PAX8 Transcription Factor | 4 | 2016 | 14 | 0.490 |
Why?
|
| Endometriosis | 4 | 2024 | 184 | 0.490 |
Why?
|
| Cystadenoma, Mucinous | 1 | 2014 | 5 | 0.470 |
Why?
|
| Endometrium | 5 | 2024 | 287 | 0.440 |
Why?
|
| Sarcoma, Endometrial Stromal | 1 | 2013 | 2 | 0.430 |
Why?
|
| Carcinoma, Adenosquamous | 1 | 2011 | 5 | 0.360 |
Why?
|
| Salpingo-oophorectomy | 3 | 2021 | 10 | 0.360 |
Why?
|
| Female | 28 | 2025 | 71586 | 0.350 |
Why?
|
| Middle Aged | 13 | 2023 | 29371 | 0.350 |
Why?
|
| Neoplasms | 2 | 2023 | 3025 | 0.340 |
Why?
|
| Uterus | 3 | 2024 | 581 | 0.340 |
Why?
|
| Alphapapillomavirus | 1 | 2011 | 50 | 0.340 |
Why?
|
| Diagnosis, Differential | 4 | 2022 | 1976 | 0.310 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2011 | 873 | 0.290 |
Why?
|
| Biopsy | 4 | 2021 | 1304 | 0.280 |
Why?
|
| Fallopian Tubes | 3 | 2024 | 78 | 0.270 |
Why?
|
| Epithelium | 3 | 2023 | 370 | 0.260 |
Why?
|
| Papillomavirus Infections | 1 | 2011 | 398 | 0.250 |
Why?
|
| Aged | 9 | 2022 | 21717 | 0.250 |
Why?
|
| Humans | 28 | 2024 | 133854 | 0.250 |
Why?
|
| Adult | 11 | 2022 | 31925 | 0.240 |
Why?
|
| Autophagy-Related Proteins | 1 | 2025 | 36 | 0.240 |
Why?
|
| Head and Neck Neoplasms | 1 | 2011 | 699 | 0.230 |
Why?
|
| Pyroptosis | 1 | 2025 | 27 | 0.230 |
Why?
|
| PAX2 Transcription Factor | 2 | 2014 | 27 | 0.230 |
Why?
|
| GATA3 Transcription Factor | 2 | 2014 | 39 | 0.230 |
Why?
|
| Paired Box Transcription Factors | 2 | 2014 | 76 | 0.230 |
Why?
|
| Aminopyridines | 1 | 2024 | 60 | 0.210 |
Why?
|
| Embryo Implantation | 2 | 2024 | 234 | 0.200 |
Why?
|
| Smad Proteins | 1 | 2023 | 43 | 0.200 |
Why?
|
| Chorionic Gonadotropin, beta Subunit, Human | 1 | 2022 | 25 | 0.200 |
Why?
|
| Epithelioid Cells | 1 | 2022 | 11 | 0.200 |
Why?
|
| Pyrroles | 1 | 2024 | 187 | 0.190 |
Why?
|
| Mucins | 1 | 2022 | 77 | 0.190 |
Why?
|
| Mucous Membrane | 1 | 2022 | 93 | 0.190 |
Why?
|
| Hysterectomy | 2 | 2021 | 192 | 0.190 |
Why?
|
| Proteogenomics | 1 | 2023 | 102 | 0.190 |
Why?
|
| Predictive Value of Tests | 2 | 2021 | 2292 | 0.190 |
Why?
|
| Neoplasm Grading | 3 | 2021 | 307 | 0.190 |
Why?
|
| Pathologists | 1 | 2021 | 30 | 0.180 |
Why?
|
| Metformin | 1 | 2023 | 162 | 0.180 |
Why?
|
| MAP Kinase Kinase Kinase 2 | 1 | 2021 | 6 | 0.180 |
Why?
|
| Forkhead Box Protein L2 | 1 | 2020 | 10 | 0.170 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2021 | 130 | 0.170 |
Why?
|
| Infertility, Female | 1 | 2021 | 148 | 0.170 |
Why?
|
| Metaplasia | 1 | 2021 | 219 | 0.170 |
Why?
|
| Carcinoma, Endometrioid | 2 | 2016 | 16 | 0.160 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2021 | 232 | 0.160 |
Why?
|
| Progesterone | 2 | 2024 | 631 | 0.160 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2021 | 258 | 0.160 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2024 | 611 | 0.160 |
Why?
|
| Squamous Intraepithelial Lesions of the Cervix | 1 | 2018 | 3 | 0.150 |
Why?
|
| Autoimmune Diseases | 1 | 2021 | 279 | 0.150 |
Why?
|
| Smad2 Protein | 1 | 2019 | 52 | 0.150 |
Why?
|
| Human Papillomavirus DNA Tests | 1 | 2018 | 8 | 0.150 |
Why?
|
| Smad3 Protein | 1 | 2019 | 59 | 0.150 |
Why?
|
| Papanicolaou Test | 1 | 2018 | 36 | 0.150 |
Why?
|
| Gastric Mucosa | 1 | 2021 | 491 | 0.150 |
Why?
|
| DNA Mutational Analysis | 1 | 2020 | 838 | 0.150 |
Why?
|
| Gastritis | 1 | 2021 | 373 | 0.150 |
Why?
|
| Infertility | 1 | 2019 | 82 | 0.140 |
Why?
|
| Pregnancy | 4 | 2025 | 7515 | 0.140 |
Why?
|
| Peritoneum | 1 | 2017 | 40 | 0.130 |
Why?
|
| Electrosurgery | 1 | 2017 | 16 | 0.130 |
Why?
|
| Omentum | 1 | 2017 | 48 | 0.130 |
Why?
|
| Proteomics | 1 | 2021 | 592 | 0.130 |
Why?
|
| Uterine Cervical Dysplasia | 1 | 2017 | 32 | 0.130 |
Why?
|
| Cell Cycle Proteins | 1 | 2021 | 697 | 0.130 |
Why?
|
| Leiomyoma | 1 | 2017 | 85 | 0.130 |
Why?
|
| Neoplasm Staging | 3 | 2021 | 1386 | 0.130 |
Why?
|
| Metabolic Syndrome | 1 | 2020 | 366 | 0.130 |
Why?
|
| Steroidogenic Factor 1 | 1 | 2016 | 35 | 0.130 |
Why?
|
| Vulvar Neoplasms | 1 | 2016 | 24 | 0.130 |
Why?
|
| Dermatofibrosarcoma | 1 | 2016 | 18 | 0.130 |
Why?
|
| Adnexal Diseases | 1 | 2016 | 23 | 0.120 |
Why?
|
| Aged, 80 and over | 4 | 2020 | 7200 | 0.120 |
Why?
|
| Adenoma | 1 | 2016 | 142 | 0.110 |
Why?
|
| Transcription Factors | 2 | 2014 | 2703 | 0.110 |
Why?
|
| Staining and Labeling | 1 | 2014 | 188 | 0.110 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2017 | 616 | 0.110 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2021 | 2122 | 0.100 |
Why?
|
| Tumor Burden | 1 | 2013 | 257 | 0.100 |
Why?
|
| Retrospective Studies | 4 | 2021 | 17457 | 0.100 |
Why?
|
| Tumor Suppressor Protein p14ARF | 1 | 2011 | 12 | 0.100 |
Why?
|
| Keratins | 1 | 2011 | 52 | 0.090 |
Why?
|
| Neoplasm Invasiveness | 1 | 2013 | 666 | 0.090 |
Why?
|
| Cell Differentiation | 2 | 2023 | 2026 | 0.090 |
Why?
|
| Papillomavirus E7 Proteins | 1 | 2011 | 24 | 0.090 |
Why?
|
| Oncogene Proteins, Viral | 1 | 2011 | 68 | 0.090 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2011 | 72 | 0.090 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2011 | 118 | 0.080 |
Why?
|
| In Situ Hybridization | 1 | 2011 | 484 | 0.080 |
Why?
|
| Fatal Outcome | 1 | 2011 | 377 | 0.080 |
Why?
|
| DNA, Viral | 1 | 2011 | 499 | 0.080 |
Why?
|
| Animals | 6 | 2025 | 36364 | 0.080 |
Why?
|
| Mice, Knockout | 3 | 2024 | 3969 | 0.080 |
Why?
|
| Mutation | 2 | 2020 | 6289 | 0.080 |
Why?
|
| RNA, Viral | 1 | 2011 | 562 | 0.070 |
Why?
|
| Mice | 5 | 2025 | 18884 | 0.070 |
Why?
|
| Oropharyngeal Neoplasms | 1 | 2011 | 283 | 0.070 |
Why?
|
| Skin Neoplasms | 1 | 2016 | 906 | 0.070 |
Why?
|
| Neoplasm Proteins | 1 | 2011 | 718 | 0.060 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2011 | 792 | 0.060 |
Why?
|
| Repressor Proteins | 1 | 2011 | 869 | 0.060 |
Why?
|
| Leukemia Inhibitory Factor | 1 | 2024 | 28 | 0.060 |
Why?
|
| Oviducts | 1 | 2025 | 338 | 0.060 |
Why?
|
| Receptors, Eph Family | 1 | 2024 | 21 | 0.060 |
Why?
|
| Receptor, EphA2 | 1 | 2024 | 29 | 0.060 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2024 | 142 | 0.050 |
Why?
|
| Time Factors | 1 | 2013 | 6584 | 0.050 |
Why?
|
| Embryo, Mammalian | 1 | 2025 | 464 | 0.050 |
Why?
|
| Small Molecule Libraries | 1 | 2024 | 139 | 0.050 |
Why?
|
| beta Catenin | 1 | 2023 | 229 | 0.050 |
Why?
|
| Disease Models, Animal | 2 | 2024 | 4772 | 0.050 |
Why?
|
| Autophagy | 1 | 2025 | 421 | 0.050 |
Why?
|
| Activin Receptors, Type II | 1 | 2021 | 33 | 0.050 |
Why?
|
| Smad5 Protein | 1 | 2021 | 22 | 0.050 |
Why?
|
| Smad1 Protein | 1 | 2021 | 23 | 0.050 |
Why?
|
| Cell Survival | 1 | 2024 | 891 | 0.050 |
Why?
|
| Phosphotransferases | 1 | 2021 | 40 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2023 | 508 | 0.040 |
Why?
|
| Health Care Surveys | 1 | 2021 | 293 | 0.040 |
Why?
|
| Cell Proliferation | 2 | 2019 | 2539 | 0.040 |
Why?
|
| Cell Movement | 1 | 2024 | 917 | 0.040 |
Why?
|
| Signal Transduction | 2 | 2024 | 4898 | 0.040 |
Why?
|
| SEER Program | 1 | 2020 | 224 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2020 | 5173 | 0.040 |
Why?
|
| Estrogens | 1 | 2021 | 521 | 0.040 |
Why?
|
| Homeostasis | 1 | 2023 | 748 | 0.040 |
Why?
|
| Phosphoproteins | 1 | 2021 | 456 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2024 | 2527 | 0.040 |
Why?
|
| DNA | 1 | 2024 | 1675 | 0.040 |
Why?
|
| Role | 1 | 2017 | 29 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2023 | 6655 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2013 | 13011 | 0.030 |
Why?
|
| BRCA2 Protein | 1 | 2017 | 52 | 0.030 |
Why?
|
| Genes, BRCA2 | 1 | 2017 | 49 | 0.030 |
Why?
|
| Genes, BRCA1 | 1 | 2017 | 61 | 0.030 |
Why?
|
| Biopsy, Needle | 1 | 2017 | 238 | 0.030 |
Why?
|
| BRCA1 Protein | 1 | 2017 | 82 | 0.030 |
Why?
|
| DNA Mismatch Repair | 1 | 2016 | 48 | 0.030 |
Why?
|
| Medicare | 1 | 2020 | 464 | 0.030 |
Why?
|
| Young Adult | 1 | 2011 | 9885 | 0.030 |
Why?
|
| Sertoli Cell Tumor | 1 | 2016 | 8 | 0.030 |
Why?
|
| Neurofibroma | 1 | 2016 | 6 | 0.030 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2017 | 173 | 0.030 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2017 | 132 | 0.030 |
Why?
|
| Carcinogenesis | 1 | 2019 | 364 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2017 | 542 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2020 | 1240 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2017 | 1134 | 0.030 |
Why?
|
| Antibodies | 1 | 2016 | 382 | 0.030 |
Why?
|
| Survival Rate | 1 | 2020 | 2207 | 0.030 |
Why?
|
| Receptors, Progesterone | 1 | 2019 | 897 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2017 | 746 | 0.030 |
Why?
|
| Transcriptome | 1 | 2021 | 1126 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2017 | 1413 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2016 | 1326 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2021 | 2196 | 0.030 |
Why?
|
| Diagnostic Errors | 1 | 2016 | 344 | 0.020 |
Why?
|
| Disease Progression | 1 | 2017 | 2239 | 0.020 |
Why?
|
| Observer Variation | 1 | 2011 | 312 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2017 | 2902 | 0.020 |
Why?
|
| Male | 2 | 2021 | 65815 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2017 | 1314 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2017 | 1911 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2019 | 2656 | 0.020 |
Why?
|
| Prognosis | 1 | 2017 | 5070 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2011 | 3051 | 0.010 |
Why?
|
| United States | 1 | 2020 | 11682 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2017 | 2764 | 0.010 |
Why?
|
| Risk Factors | 1 | 2017 | 11078 | 0.010 |
Why?
|